• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒感染与肾癌之间联系的新见解

New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer.

作者信息

Rago Vittoria, Bossio Sabrina, Lofaro Danilo, Perri Anna, Di Agostino Silvia

机构信息

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, 88100 Catanzaro, Italy.

出版信息

Life (Basel). 2023 Dec 28;14(1):52. doi: 10.3390/life14010052.

DOI:10.3390/life14010052
PMID:38255667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10817602/
Abstract

Cancer has been described as a risk factor for greater susceptibility to SARS-CoV-2 infection and severe COVID-19, mainly for patients with metastatic disease. Conversely, to that reported for most solid and hematological malignancies, the few available clinical studies reported that the infection did not increase the risk of death in renal cancer patients. The expression on proximal tubular renal cells of the key players in cellular viral uptake, ACE2, TMPRSS2, and NRP1, seems to be the mechanism for the direct kidney injury seen in patients with COVID-19. Interestingly, data from The Cancer Genome Atlas and experimental analyses on various renal cancer cell lines demonstrated that the above-reported receptors/cofactors are maintained by renal cancer cells. However, whether SARS-CoV-2 infection directly kills renal cancer cells or generates enhanced immunogenicity is a question worth investigating. In addition, some researchers have further addressed the topic by studying the expression and prognostic significance of gene signatures related to SARS-CoV-2 infection in renal cancer patients. The emerging data highlights the importance of better understanding the existence of a link between renal cancer and COVID-19 since it could lead to the identification of new prognostic factors and the development of new therapeutic targets in the management of renal cancer patients.

摘要

癌症已被描述为更易感染SARS-CoV-2和患重症新冠肺炎的一个风险因素,主要针对患有转移性疾病的患者。相反,与大多数实体和血液系统恶性肿瘤的报道情况不同,为数不多的现有临床研究报告称,感染并未增加肾癌患者的死亡风险。细胞病毒摄取关键因子ACE2、TMPRSS2和NRP1在近端肾小管细胞上的表达,似乎是新冠肺炎患者出现直接肾损伤的机制。有趣的是,癌症基因组图谱的数据以及对各种肾癌细胞系的实验分析表明,上述受体/辅助因子由肾癌细胞维持。然而,SARS-CoV-2感染是否直接杀死肾癌细胞或产生增强的免疫原性是一个值得研究的问题。此外,一些研究人员通过研究肾癌患者中与SARS-CoV-2感染相关的基因特征的表达及其预后意义,进一步探讨了这一话题。新出现的数据凸显了更好地理解肾癌与新冠肺炎之间联系的重要性,因为这可能有助于识别新的预后因素,并在肾癌患者的管理中开发新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4512/10817602/d80938d2bd2e/life-14-00052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4512/10817602/d80938d2bd2e/life-14-00052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4512/10817602/d80938d2bd2e/life-14-00052-g001.jpg

相似文献

1
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer.新型冠状病毒感染与肾癌之间联系的新见解
Life (Basel). 2023 Dec 28;14(1):52. doi: 10.3390/life14010052.
2
Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.肾类器官揭示 ACE2 依赖性 SARS-CoV-2 感染过程中病毒进入途径的冗余性。
J Virol. 2024 Mar 19;98(3):e0180223. doi: 10.1128/jvi.01802-23. Epub 2024 Feb 9.
3
Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.SARS-CoV-2 通过代谢和免疫调节下调 ACE2 表达,使 KIRC 和 KIRP 患者的预后恶化。
Int J Biol Sci. 2021 May 10;17(8):1925-1939. doi: 10.7150/ijbs.57802. eCollection 2021.
4
Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium.单细胞 RNA 测序分析 SARS-CoV-2 感染妊娠前期人子宫内膜的细胞进入因子。
Hum Reprod. 2021 Sep 18;36(10):2709-2719. doi: 10.1093/humrep/deab183.
5
SARS-CoV-2 Causes Acute Kidney Injury by Directly Infecting Renal Tubules.严重急性呼吸综合征冠状病毒2型通过直接感染肾小管导致急性肾损伤。
Front Cell Dev Biol. 2021 May 31;9:664868. doi: 10.3389/fcell.2021.664868. eCollection 2021.
6
Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.表观遗传学靶向 ACE2 和 NRP1 病毒受体可限制 SARS-CoV-2 感染性。
Clin Epigenetics. 2021 Oct 11;13(1):187. doi: 10.1186/s13148-021-01168-5.
7
and expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.并通过 34 种人类癌症及匹配的正常组织中的临床、HLA、免疫和微生物相关性进行表达:对 SARS-CoV-2 COVID-19 的影响。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-001020.
8
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.ACE2 和 TMPRSS2 可能参与癌症患者对 SARS-CoV-2 的遗传易感性。
Cell Transplant. 2020 Jan-Dec;29:963689720968749. doi: 10.1177/0963689720968749.
9
BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes.BSG/CD147和ACE2受体促进严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染人诱导多能干细胞衍生的肾足细胞。
bioRxiv. 2021 Nov 17:2021.11.16.468893. doi: 10.1101/2021.11.16.468893.
10
Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection.年龄、性别和地塞米松治疗对 ACE2/TMPRSS2 表达和对 SARS-CoV-2 感染易感性的差异影响。
Front Immunol. 2022 Nov 3;13:1021928. doi: 10.3389/fimmu.2022.1021928. eCollection 2022.

引用本文的文献

1
Angiotensin‑converting enzyme 2 expression in human tumors: Implications for prognosis and therapy (Review).血管紧张素转换酶2在人类肿瘤中的表达:对预后和治疗的影响(综述)
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8934. Epub 2025 Jun 27.
2
SARS-CoV-2 Spike Protein Amplifies the Immunogenicity of Healthy Renal Epithelium in the Presence of Renal Cell Carcinoma.严重急性呼吸综合征冠状病毒2刺突蛋白在肾细胞癌存在的情况下增强健康肾上皮细胞的免疫原性。
Cells. 2024 Dec 10;13(24):2038. doi: 10.3390/cells13242038.
3
Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction.

本文引用的文献

1
COVID-19 and Kidney: The Importance of Follow-Up and Long-Term Screening.2019冠状病毒病与肾脏:随访及长期筛查的重要性
Life (Basel). 2023 Oct 30;13(11):2137. doi: 10.3390/life13112137.
2
Transcriptomic Analysis in Renal Cell Carcinoma and COVID-19 patients.肾细胞癌和 COVID-19 患者的转录组分析。
Cell Mol Biol (Noisy-le-grand). 2023 Aug 31;69(8):156-162. doi: 10.14715/cmb/2023.69.8.24.
3
Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study.
透明细胞肾癌中组蛋白修饰特征的综合分析用于风险分层和治疗预测。
Transl Oncol. 2024 Sep;47:102042. doi: 10.1016/j.tranon.2024.102042. Epub 2024 Jun 25.
评估 COVID19 对接受抗血管生成或免疫治疗的晚期肾癌患者影响的病例对照研究:COVID-REN 研究。
Clin Transl Oncol. 2024 Mar;26(3):732-738. doi: 10.1007/s12094-023-03295-2. Epub 2023 Aug 9.
4
Impact of the COVID-19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study.COVID-19 大流行对小儿肾肿瘤表现和治疗的影响,SIOP 肾肿瘤研究组研究。
Cancer Med. 2023 Aug;12(16):17098-17111. doi: 10.1002/cam4.6358. Epub 2023 Jul 26.
5
Plausibility of natural immunomodulators in the treatment of COVID-19-A comprehensive analysis and future recommendations.天然免疫调节剂治疗COVID-19的合理性——全面分析与未来建议
Heliyon. 2023 Jun;9(6):e17478. doi: 10.1016/j.heliyon.2023.e17478. Epub 2023 Jun 21.
6
Integrin β1 is a key determinant of the expression of angiotensin-converting enzyme 2 (ACE2) in the kidney epithelial cells.整合素β1 是肾脏上皮细胞中血管紧张素转化酶 2(ACE2)表达的关键决定因素。
Eur J Cell Biol. 2023 Jun;102(2):151316. doi: 10.1016/j.ejcb.2023.151316. Epub 2023 Apr 18.
7
Treating COVID-19: Targeting the Host Response, Not the Virus.治疗新冠病毒病:针对宿主反应,而非病毒。
Life (Basel). 2023 Mar 6;13(3):712. doi: 10.3390/life13030712.
8
Identification of the regulatory mechanism of ACE2 in COVID-19-induced kidney damage with systems genetics approach.采用系统遗传学方法鉴定 ACE2 在 COVID-19 诱导的肾损伤中的调控机制。
J Mol Med (Berl). 2023 Apr;101(4):449-460. doi: 10.1007/s00109-023-02304-9. Epub 2023 Mar 23.
9
Uncovering a link between COVID-19 and renal cell carcinoma.揭示 COVID-19 与肾细胞癌之间的关联。
Nat Rev Urol. 2023 Jun;20(6):330-331. doi: 10.1038/s41585-023-00749-8.
10
Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma.溶瘤腺病毒介导的CCL5和IL12表达促进靶向碳酸酐酶IX的嵌合抗原受体T细胞疗法治疗肾细胞癌。
Pharmacol Res. 2023 Mar;189:106701. doi: 10.1016/j.phrs.2023.106701. Epub 2023 Feb 14.